These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28420093)

  • 1. Potential Role of Free Fatty Acids in the Pathogenesis of Periodontitis and Primary Sjögren's Syndrome.
    Shikama Y; Kudo Y; Ishimaru N; Funaki M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation in Sjögren's syndrome: Cause or consequence?
    Rodrigues AR; Soares R
    Autoimmunity; 2017 May; 50(3):141-150. PubMed ID: 28276715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The evaluation of chosen cytokines in induction of ocular changes in Sjögren's syndrome of dry eye].
    Zywalewska-Górna N; Mrugacz M; Bakunowicz-Lazarczyk A
    Klin Oczna; 2007; 109(10-12):435-7. PubMed ID: 18488390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essential fatty acid metabolism in diseases of connective tissue with special reference to scleroderma and to Sjogren's syndrome.
    Horrobin DF
    Med Hypotheses; 1984 Jul; 14(3):233-47. PubMed ID: 6088955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sjögren's syndrome, a manifestation of vitamin B complex deficiency. Statistical study of 98 cases in 17 years].
    Altamar Ríos J
    An Otorrinolaringol Ibero Am; 1985; 12(5):443-57. PubMed ID: 4083442
    [No Abstract]   [Full Text] [Related]  

  • 6. JAK Inhibitors Suppress Innate Epigenetic Reprogramming: a Promise for Patients with Sjögren's Syndrome.
    Charras A; Arvaniti P; Le Dantec C; Arleevskaya MI; Zachou K; Dalekos GN; Bordon A; Renaudineau Y
    Clin Rev Allergy Immunol; 2020 Apr; 58(2):182-193. PubMed ID: 31165348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sjögren's syndrome: a review of aetiology, pathogenesis, diagnosis and management.
    Bayetto K; Logan RM
    Aust Dent J; 2010 Jun; 55 Suppl 1():39-47. PubMed ID: 20553243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjogren's syndrome and the sicca syndrome: the role of prostaglandin E1 deficiency. Treatment with essential fatty acids and vitamin C.
    Horrobin DF; Campbell A
    Med Hypotheses; 1980 Mar; 6(3):225-32. PubMed ID: 7432243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren's syndrome: from pathogenesis to novel therapeutic targets.
    Barone F; Colafrancesco S
    Clin Exp Rheumatol; 2016; 34(4 Suppl 98):58-62. PubMed ID: 27586806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMADS-Mediate Molecular Mechanisms in Sjögren's Syndrome.
    Sisto M; Ribatti D; Lisi S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren's Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis.
    Shen L; He J; Kramer JM; Bunya VY
    J Immunol Res; 2019; 2019():8101503. PubMed ID: 31236421
    [No Abstract]   [Full Text] [Related]  

  • 12. Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis.
    Nezos A; Gravani F; Tassidou A; Kapsogeorgou EK; Voulgarelis M; Koutsilieris M; Crow MK; Mavragani CP
    J Autoimmun; 2015 Sep; 63():47-58. PubMed ID: 26183766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of free fatty acids on human salivary gland epithelial cells.
    Shikama Y; Ishimaru N; Kudo Y; Bando Y; Aki N; Hayashi Y; Funaki M
    J Dent Res; 2013 Jun; 92(6):540-6. PubMed ID: 23603335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New advances in the classification, pathogenesis and treatment of Sjogren's syndrome.
    Mavragani CP; Nezos A; Moutsopoulos HM
    Curr Opin Rheumatol; 2013 Sep; 25(5):623-9. PubMed ID: 23846338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of Sjögren's syndrome.
    García-Carrasco M; Fuentes-Alexandro S; Escárcega RO; Salgado G; Riebeling C; Cervera R
    Arch Med Res; 2006 Nov; 37(8):921-32. PubMed ID: 17045106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential fatty acid and prostaglandin metabolism in Sjögren's syndrome, systemic sclerosis and rheumatoid arthritis.
    Horrobin DF
    Scand J Rheumatol Suppl; 1986; 61():242-5. PubMed ID: 3296151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in understanding the pathogenesis of Sjögren's syndrome in non-obese diabetic mice].
    Su YC; Wu LL; Xiang RL
    Sheng Li Ke Xue Jin Zhan; 2012 Jun; 43(3):171-6. PubMed ID: 23019918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet serotonin in primary Sjögren's syndrome: level and relation with disease activity.
    Sarac H; Markeljevic J; Mokrovic G; Erdeljic V; Bozina N; Cicin-Sain L
    J Neuroimmunol; 2012 Oct; 251(1-2):87-9. PubMed ID: 22819441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential involvement of the IL-33-ST2 axis in the pathogenesis of primary Sjogren's syndrome.
    Awada A; Nicaise C; Ena S; Schandéné L; Rasschaert J; Popescu I; Gangji V; Soyfoo MS
    Ann Rheum Dis; 2014 Jun; 73(6):1259-63. PubMed ID: 24385203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible Involvement of Palmitate in Pathogenesis of Periodontitis.
    Shikama Y; Kudo Y; Ishimaru N; Funaki M
    J Cell Physiol; 2015 Dec; 230(12):2981-9. PubMed ID: 25921577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.